GLP-1 Analogues Market Set for Rapid Expansion in Diabetes & Obesity Treatment
The global GLP-1 analogues market is experiencing tremendous growth, driven by the increasing prevalence of metabolic disorders and the rising adoption of innovative therapies. The global GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% during the forecast period. Factors such as increasing manufacturing capacities and capabilities...